![Monica Bertagnolli’s Cancer Plan makes the most of her two roles: NCI director and leader of the National Cancer Program](https://cdn.cancerletter.com/media/2023/04/14150900/49-15-Bertagnolli-4x3-1.jpg)
![Monica Bertagnolli’s Cancer Plan makes the most of her two roles: NCI director and leader of the National Cancer Program](https://cdn.cancerletter.com/media/2023/04/14150900/49-15-Bertagnolli-4x3-1.jpg)
Cover Story
Conversation with The Cancer LetterFree
By Paul Goldberg and Matthew Bin Han Ong
This point is easily overlooked: Monica Bertagnolli has two jobs, not one. She is the director of the National Cancer Institute and head of the National Cancer Program.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Funding Opportunities
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
Trending Stories
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Proposed rule by CMS would expand access to cancer treatment at tribal facilities
- A view from the BMT unit on the day a Russian cruise missile hit Kyiv’s Ohmatdyt hospital
- Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”